Chromogranin a measurement for assessing the selectivity of adrenal venous sampling in primary aldosteronism

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 5, 2011, Pages

  Seccia, Teresa M ^a   Miotto, Diego ^a   De Toni, Renzo ^a   Maniero, Carmela ^a   Vincenzi, Matteo ^a   Motta, Raffaella ^a   Pessina, Achille C ^a   Rossi, Gian Paolo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; HYDROCORTISONE;

ADRENAL GLAND; ADRENAL VEIN SAMPLING; ADRENALECTOMY; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; INFERIOR CAVA VEIN; INFRARENAL INFERIOR CAVA VEIN; MALE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SENSITIVITY AND SPECIFICITY; VENOUS BLOOD;

ADRENAL GLANDS; ALDOSTERONE; BLOOD SPECIMEN COLLECTION; CHROMOGRANIN A; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; HYDROCORTISONE; HYPERALDOSTERONISM; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; SAMPLE SIZE; TUMOR MARKERS, BIOLOGICAL; VENA CAVA, INFERIOR;

EID: 79955663753     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-2172     Document Type: Article

References (20)

1. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F, PAPY Study Investigators 2006 A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48:2293-2300 (Pubitemid 44873058)
2. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young Jr WF, Montori VM 2008 Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:3266-3281
3. Miotto D, De Toni R, Pitter G, Seccia TM, Motta R, Vincenzi M, Feltrin G, Rossi GP 2009 Impact of accessory hepatic veins on adrenal vein sampling for identification of surgically curable primary aldosteronism. Hypertension 54:885-889
4. Rossi GP, Pitter G, Bernante P, Motta R, Feltrin G, Miotto D 2008 Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation. J Hypertens 26:989-997 (Pubitemid 351520987)
5. Rossi GP, Sacchetto A, Chiesura-Corona M, De Toni R, Gallina M, Feltrin GP, Pessina AC 2001 Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab 86:1083-1090 (Pubitemid 32322986)
6. Stewart PM, Allolio B 2010 Adrenal vein sampling for primary aldosteronism: time for a reality check. Clin Endocrinol (Oxf) 72:146-148
7. Freel EM, Stanson AW, Thompson GB, Grant CS, Farley DR, Richards ML, Young Jr WF 2010 Adrenal venous sampling for catecholamines: a normal value study. J Clin Endocrinol Metab 95: 1328-1332
8. Koshimizu H, Kim T, Cawley NX, Loh YP 2010 Chromogranin A: a new proposal for trafficking, processing and induction of granule biogenesis. Regul Pept 160:153-159
9. Crivellato E, Nico B, Ribatti D 2008 The chromaffin vesicle: advances in understanding the composition of a versatile, multifunctional secretory organelle. Anat Rec (Hoboken) 291:1587-1602
10. Rossi GP 2011 Does primary aldosteronism exist in normotensive and mildly hypertensive patients, and should we look for it? Hypertens Res 34:43-46
11. Young Jr WF 2007 Adrenal causes of hypertension: pheochromocytoma and primary aldosteronism. Rev Endocr Metab Disord 8:309-320
12. Rossi GP, Ganzaroli C, Miotto D, De Toni R, Palumbo G, Feltrin GP, Mantero F, Pessina AC 2006 Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients. J Hypertens 24:371-379 (Pubitemid 43348251)
13. Rossi GP, Seccia TM, Palumbo G, Belfiore A, Bernini G, Caridi G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Patalano A, Rizzoni D, Rossi E, Pessina AC, Mantero F, Primary Aldosteronism in the Prevalence in Hypertension (PAPY) Study Investigators 2010 Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism. Hypertension 55:83-89
14. Rossi GP 2007 New concepts in adrenal vein sampling for aldosterone in the diagnosis of primary aldosteronism. Curr Hypertens Rep 9:90-97 (Pubitemid 46779372)
15. Young WF, Stanson AW 2009 What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism? Clin Endocrinol (Oxf) 70:14-17
16. Auchus RJ, Wians Jr FH, Anderson ME, Dolmatch BL, Trimmer CK, Josephs SC, Chan D, Toomay S, Nwariaku FE 2010 What we still do not know about adrenal vein sampling for primary aldosteronism. Horm Metab Res 42:411-415
17. Barakat MT, Meeran K, Bloom SR 2004 Neuroendocrine tumours. Endocr Relat Cancer 11:1-18 (Pubitemid 38419720)
18. Baudin E, Bidart JM, Bachelot A, Ducreux M, Elias D, Ruffie P, Schlumberger M 2001 Impact of chromogranin A measurement in the work-up of neuroendocrine tumors. Ann Oncol 12(Suppl 2):S79-S82 (Pubitemid 33069692)
19. Montero-Hadjadje M, Ait-Ali D, Turquier V, Guillemot J, Boutahritch M, Magoul R, Malagon MM, Yon L, Vaudry H, Anouar Y 2006 Chromogranins/ secretogranins and derived peptides: insights from the amphibian model. In: Kastin AJ, ed. Handbook of biologically active peptides. New York: Academic Press; 311-319
20. Modlin IM, Gustafsson BI, Moss SF, Pavel M, Tsolakis AV, Kidd M 2010 Chromogranin A - biological function and clinical utility in neuroendocrine tumor disease. Ann Surg Oncol 17:2427-2443